2009.10.17 Weekly Broadcast Email

The following updates were made to the website for the week of October 12, 2009. ________________________________________ 91105: Phase III Double Blind, Placebo Controlled Study of Donepezil in Irradiated Brain Tumor Patients Amendment 8 has been added to the website. This amendment includes changes to the protocol, consent and appendices 2, 12, 13, 14 and 16. ________________________________________ Reminder: 97106 (Randomized Study to Determine whether ArginMax Improves the Sexual Function and Quality of Life in Female Cancer Survivors) only has 9 minority accrual slots open for patient accruals. We would like to see this study close by the end of the summer, so if you have patients that may be eligible for this study, please try and get them registered by then.

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.